newsfilter
← Latest News
GlobeNewswire·

Solésence, Inc. Announces Appointment of New Independent Director

  • Solésence, Inc. appointed Marc James as an independent director to its Board of Directors effective immediately on April 27, 2026.
  • James will serve on the Audit Committee, Compensation Committee, & Nominating Committee.
  • The appointment supports Solésence's "Transform & Transcend" strategic initiative & long-term growth objectives.
  • James brings senior executive experience in global financial markets, capital markets activities, interest rate risk management, & financing strategies.
  • CEO Kevin Cureton stated James's perspective will be an asset as the Company scales operations & expands brand partner relationships.
  • Board Chair Janet Whitmore noted James's appointment expands the Board's expertise to support disciplined execution & sustainable profitable growth.
  • Solésence is a NASDAQ-listed leader (ticker: SLSN) providing scientifically-driven health care solutions in beauty & life science categories.